Cocuzza C, Blandino G, Mattina R, Nicoletti F, Nicoletti G
Institute of Microbiology, University of Milano, Italy.
Microb Drug Resist. 1997 Winter;3(4):379-84. doi: 10.1089/mdr.1997.3.379.
Resistance to macrolides has increasingly been reported for Group A streptococci. In this study, the in vitro antibiotic susceptibility pattern of 305 clinical isolates of S. pyogenes was determined. Strains were isolated during 1996 from pharyngeal swabs of children with uncomplicated pharyngitis living in 2 Italian cities: Milano and Catania, situated in the North and South of Italy, respectively. All isolates were found to be fully susceptible to penicillin and other beta-lactam agents tested. Susceptibility to macrolides differed markedly between the two centers with relatively high resistance rates to erythromycin being observed in Milano (30%) as compared to Catania (3%). Resistance to erythromycin was always crossed with that of the other 14- and 15-membered macrolides tested. However, resistance to josamycin and clindamycin was generally found in approximately 25% of the erythromycin-resistant (ER) strains. The erythromycin-resistant isolates from Milano and Catania (58 strains) were further subdivided into the three previously described resistance phenotypes: constitutive, inducible, and novel resistance phenotypes. The novel resistance phenotype accounted for 58% of all resistant strains, while 17% and 26% were found to be of the inducible and constitutive resistance phenotypes. Strains of the novel resistance phenotype were characterized by lower MIC values (MIC90 = 16 mg/L) to 14 and 15 carbon atom macrolides as compared to the other two phenotypes (MIC90 > 128 mg/L), and retained susceptibility to clindamycin and to josamycin, a 16 carbon atom macrolide. Resistance to tetracyclines was found in 25% to 36% of the ER isolates as compared to 2% to 10% of the susceptible strains. In particular, resistance to this agent was more commonly associated to isolates belonging to the novel and constitutive resistance phenotypes. MIC values for chloramphenicol in all isolates were within the susceptible or intermediate range; decreased susceptibility to this agent did not appear to be associated with erythromycin resistance.
A组链球菌对大环内酯类药物的耐药性报道日益增多。在本研究中,测定了305株化脓性链球菌临床分离株的体外抗生素敏感性模式。这些菌株于1996年从居住在意大利两个城市(分别位于意大利北部的米兰和南部的卡塔尼亚)的患单纯性咽炎儿童的咽拭子中分离得到。所有分离株对青霉素和其他所检测的β-内酰胺类药物均完全敏感。两个中心对大环内酯类药物的敏感性差异显著,米兰对红霉素的耐药率相对较高(30%),而卡塔尼亚则为3%。对红霉素的耐药性总是与所检测的其他14元和15元大环内酯类药物的耐药性交叉。然而,在大约25%的耐红霉素(ER)菌株中通常发现对交沙霉素和克林霉素耐药。来自米兰和卡塔尼亚的耐红霉素分离株(58株)进一步细分为先前描述的三种耐药表型:组成型、诱导型和新型耐药表型。新型耐药表型占所有耐药菌株的58%,而诱导型和组成型耐药表型分别占17%和26%。与其他两种表型(MIC90>128mg/L)相比,新型耐药表型菌株对14和15碳原子大环内酯类药物的MIC值较低(MIC90=16mg/L),并且对克林霉素和16碳原子大环内酯类药物交沙霉素仍敏感。与2%至10%的敏感菌株相比,25%至36%的ER分离株对四环素耐药。特别是,对该药物的耐药性更常见于属于新型和组成型耐药表型的分离株。所有分离株中氯霉素的MIC值均在敏感或中介范围内;对该药物敏感性降低似乎与红霉素耐药性无关。